Myelography complications and current practice patterns

American Journal of Roentgenology

Volumn 185, Issue 3, 2005, Pages 768-771

  Sandow, Bruce A ^a   Donnal, John F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTROLLED STUDY; E-MAIL; HEALTH SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MYELOGRAPHY; NEURORADIOLOGY; PRIORITY JOURNAL; SCREENING; SEIZURE; SOCIETY; CLINICAL PRACTICE; QUESTIONNAIRE; RISK FACTOR; STATISTICS; UNITED STATES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; MYELOGRAPHY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 27744593663     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.185.3.01850768     Document Type: Article

References (7)

1. Robertson HJ, Smith RD. Cervical myelography: survey of modes of practice and major complications. Radiology 1990; 174:79-83
2. Fedutes BA, Ansani NT. Seizure potential of concomitant medications and radiographic contrast media agents. Ann Pharmacother 2003; 37:1506-1510
3. Smith RR. Myelographic complications associated with drug interactions. (answer to question) AJR 2001; 177:713
4. Henry WD. Metformin hydrochloride in patients undergoing myelography (letter). AJR 2002; 178:1289
5. van der Leede H, Jorens PG, Parizel P, Cras P. Inadvertent intrathecal use of ionic contrast agent. Eur Radiol 2002; 12[suppl 3]:S86-S93
6. ISMP Medication Safety Alert. Intrathecal injection of ionic contrast media may be fatal. November 27, 2003. Available at: www.ismp.org/MSAarticles/ fatal.htm. Accessed May 15, 2005
7. Wald C, Luchs J, Davila J, et al. Residents' perceptions of MRI training in the United States. JACR 2004; 1:331-337